Literature DB >> 1835239

Natural killer cells and lymphocyte subsets in active MS and acute inflammation of the CNS.

E Merelli1, P Sola, P Faglioni, S Giordani, D Mussini, G Montagnani.   

Abstract

Cerebrospinal fluid (CSF) and peripheral blood (PB) lymphocyte subsets were determined by flow cytometry (FCM) in 15 patients with active multiple sclerosis (MS) and 15 patients with acute inflammatory diseases (ID) of the central nervous system (CNS) in order to establish correlations between the two groups of diseases, as well as between the CSF and PB subsets distribution. A panel of monoclonal antibodies was applied to all the samples: Leu3 (CD4), Leu4 (CD3), Leu2 (CD8), Anti-HLA-DR, Leu11 (CD16). Statistical analysis did not show differences in CD3+ nor in CD3+ DR+ T-cells both in the CSF and PB in the two groups of patients. CD4+ cells were significantly higher in the CSF than in the PB, while CD8+, DR+ CD3- and CD16+ cells were constantly lower in the CSF without differences between the two groups of diseases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835239     DOI: 10.1111/j.1600-0404.1991.tb04920.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  3 in total

1.  Immunological differentiation between tickborne encephalitis with and without concomitant neuroborreliosis.

Authors:  J Tomazic; A Ihan; F Strle; J Cimperman; J Stare; M Maticic; B Zakotnik
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

Review 2.  Dendritic cells and multiple sclerosis: disease, tolerance and therapy.

Authors:  Mohammad G Mohammad; Masoud Hassanpour; Vicky W W Tsai; Hui Li; Marc J Ruitenberg; David W Booth; Jordi Serrats; Prue H Hart; Geoffrey P Symonds; Paul E Sawchenko; Samuel N Breit; David A Brown
Journal:  Int J Mol Sci       Date:  2012-12-27       Impact factor: 5.923

3.  Cytotoxic B Cells in Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Vinícius O Boldrini; Ana M Marques; Raphael P S Quintiliano; Adriel S Moraes; Carla R A V Stella; Ana Leda F Longhini; Irene Santos; Marília Andrade; Breno Ferrari; Alfredo Damasceno; Rafael P D Carneiro; Carlos Otávio Brandão; Alessandro S Farias; Leonilda M B Santos
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.